ZYNCHROS EXTENDS FORMULARY DISTRIBUTION TO INCLUDE EPOCRATES
Integration accelerates delivery of timely Formulary data to the Point-of-Care
Seattle, WA – February 22, 2007 – Zynchros, Inc., today announced a collaboration with Epocrates, Inc., of San Mateo, California. Under the agreement, the two companies will develop a sophisticated translation and delivery solution that will allow joint health plan customers to have the option to automatically translate approved drug lists (formularies) to an Epocrates-compatible format, and electronically deliver those lists to Epocrates' databases. Epocrates, developer of mobile and web-based clinical reference solutions, will then make the formulary information available to the more than 500,000 healthcare professionals that actively use their product. The ability to access the newly available coverage information when prescribing a new medication for their patient will ensure it is the most efficacious and cost-effective medication treatment.
“We are committed to providing our health plan clients with the broadest range of tools and technologies that allow them to take control of their pharmacy benefit program in a streamlined and cost-effective form”, said Robert Pinkerton, president and COO of Zynchros. “With more than half a million users of the Epocrates solution, we feel this integration will significantly accelerate the distribution of pharmaco-economic information to doctors, ensuring a more cost-effective prescribing decision at the point-of-care.”
“At Epocrates we want to offer options for our health plan clients to deliver updated formulary information. Utilizing Zynchros’ integrated formulary management process provides a new option for our clients that may reduce paper work and increase efficiencies,” said Jeff Tangney, co-founder and executive vice president of sales and marketing for Epocrates.
“Today, we enable our health plan clients to take a holistic view of their Pharmacy Benefit program – from the decisions made by Pharmacy & Therapeutics committees to the point-of-care,” said Marc Lilly, chairman and CEO of Zynchros. “Using technology to compress the time it takes for a P & T decision to make its way to the sharp-end of health care delivery not only reduces operating costs for our clients but presents them with the opportunity for tremendous cost-savings in pharmacy spending. The broad adoption of Epocrates’ products provides our clients with a wide-spread platform to educate and inform both providers and patients as to their best treatment choices.”
PRICING AND AVAILABILITY
The integrated solution will be available in Q2, 2007. Pricing has yet to be determined.
ABOUT EPOCRATES, INC.
San Mateo, Calif.-based Epocrates is transforming the practice of medicine by developing innovative solutions that support clinical decisions at the point of care. More than 500,000 healthcare professionals, including more than one in four U.S. physicians, actively use Epocrates' mobile and web-based products to improve patient safety and save time. The company’s offerings also enable communication between its users and healthcare organizations such as government agencies, pharmaceutical manufacturers and market research firms. Epocrates has been on the Inc. 500 fastest-growing private companies list for two consecutive years - ranking 176 in 2006. For more information about Epocrates, please visit www.epocrates.com.
ABOUT ZYNCHROS, INC.
Founded in 2000, privately-held Zynchros, Inc. (formerly Script IQ, Inc.) delivers
technology-based solutions that transform the economics of drug-based wellness,
improving compliance and agility of health insurers and pharmacy benefit managers. The
Zynchros.com on-demand platform provides the workflow processes necessary to initiate
pharmacy quality management, improving responsiveness, control and efficiency by
synchronizing all of the participants in pharmacy benefits, from P&T to the point of care.
To learn more about how Zynchros is interconnecting the world of pharmacy benefits
visit www.zynchros.com or call 1-866-996-2476.
For more information contact:
EPOCRATES, INC.
Erica Sniad
650.227.6907
pr@epocrates.com
ZYNCHROS, INC.
Terry Christiani
206.792.4106
terry.christiani@zynchros.com

